Search

In this study, three CuFe-MOFs were successfully synthesized by a solvothermal process by changing the ratio of solvents, salts, or temperature. These MOFs named CuFe(BDC-NH2)R, CuFe(BDC-NH2)S, and CuFe(BDC-NH2)D showed rod-shaped, spindle-like, and diamond-like structures, respectively. The CuFe(BDC-NH2)D and CuFe(BDC-NH2)S were found to exhibit an improved PMS activation for Rhodamine B removal attaining levels around 92%. Their effective removal capability was investigated as a function of the pH, catalyst dosage, and the effect of the application of UV radiation. The best degradation system was photo-assisted activation of PMS when CuFe(BDC-NH2)D and CuFe(BDC-NH2)S were used. Under these conditions, the degradation of a mixture of antibiotic and anti-inflammatory drugs (sulfamethoxazole and antipyrine) was evaluated with the results revealing the total degradation of both drugs after 1 h. A higher antibacterial activity was attained with the system CuFe(BDC-NH2)R/PMS due to the high copper content with respect to the others. Ministerio de Ciencia e Innovación | Ref. PCI2022-132941 Ministerio de Ciencia e Innovación | Ref. PID2020-113667GBI00 Xunta de Galicia | Ref. ED431C 2021-43

The development of novel approaches to the remotion of pharmaceuticals in wastewater is a subject of concern due to their effect on living beings and the environment. Advanced oxidation processes and the use of relevant catalysts are feasible treatment alternatives that require further development. The development of suitable heterogeneous catalysts is a necessity. This work proposes the synthesis of an iron catalyst in a deep eutectic solvent (Fe-DES) composed of choline chloride and citric acid, which was physically and chemically characterized using SEM-EDS and TEM, FTIR, RAMAN, XRD and XPS. The characterisation confirmed the presence of iron in the form of hematite. Fe-DES was shown to be a multipurpose catalyst that can be applied in the removal of sulfamethoxazole as a reagent in the Fenton and electro-Fenton processes and as an activator of peroxymonosulfate (PMS) processes. After testing the catalyst with the aforementioned techniques, the best result was achieved by combining these processes in an electro-PMS, with great efficiency achieved by dual activation of the PMS with the catalyst and electric field, attaining total elimination at natural pH in 90 min. Furthermore, the degradation was confirmed by the detection of short-chain carboxylic acids (oxalic, succinic, and acetic) and reduction in toxicity values. These results confirm the suitability of Fe-DES to degrade high-priority pharmaceutical compounds. Xunta de Galicia y FEDER | Ref. ED431C 2021-43 Ministerio de Ciencia e Innovación | Ref. PCI2022-132941 Ministerio de Ciencia e Innovación | Ref. PDC2021-121394-I00